[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100601356":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":28,"responsibleParty":62,"collaborators":18,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":68,"acronym":18,"eligibilityCriteria":69,"healthyVolunteers":70,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":18,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":84,"overallStatus":30,"whyStopped":18,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Washington University School of Medicine","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Annual PSA Health Maintenance Reminder","EXPERIMENTAL","An annual health maintenance reminder will be implemented for all men who meet the American Cancer Society guidelines for average- and high-risk eligibility criteria. The goal is to encourage their primary care provider (PCP) to engage in a shared decision-making discussion with the patient about the benefits and risks of prostate cancer screening.\n\nThis alert will appear in the health maintenance reminder section of the electronic health record (EHR).\n\nAlthough all providers with access to EPIC can view the alert, it is typically the PCPs who review and take action on alerts in the health maintenance reminder section.",[13],"Other: Annual PSA Health Maintenance Reminder",[15],{"type":6,"name":9,"description":16,"armGroupLabels":17,"otherNames":18},"The annual health maintenance reminder does not mandate PSA screening for eligible patients. Instead, it recommends that primary care providers (PCPs) initiate a shared decision-making discussion with their patients. As part of this conversation, patients will be informed of their individual risk factors-including race, family history, and germline mutations-and can then make an informed choice about whether to proceed with PSA screening.",[9],null,[20],{"name":21,"affiliation":5,"role":22},"Lannis Hall, M.D., MPH","PRINCIPAL_INVESTIGATOR",[24],{"name":21,"role":25,"phone":26,"phoneExt":18,"email":27},"CONTACT","636-916-9947","lannishall@wustl.edu",[29],{"facility":5,"status":30,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"RECRUITING","St Louis","Missouri","63110","United States","US",{"type":37,"coordinates":38},"Point",[39,40],-90.19789,38.62727,{"lat":40,"lon":39},[43,44,45,48,50,52,54,56,58,60],{"name":21,"role":25,"phone":26,"phoneExt":18,"email":27},{"name":21,"role":22,"phone":18,"phoneExt":18,"email":18},{"name":46,"role":47,"phone":18,"phoneExt":18,"email":18},"Saira Khan, Ph.D., MPH","SUB_INVESTIGATOR",{"name":49,"role":47,"phone":18,"phoneExt":18,"email":18},"Arnold Bullock, M.D.",{"name":51,"role":47,"phone":18,"phoneExt":18,"email":18},"Timothy Eberlein, M.D.",{"name":53,"role":47,"phone":18,"phoneExt":18,"email":18},"Kristina Williams",{"name":55,"role":47,"phone":18,"phoneExt":18,"email":18},"Cliff Robinson, M.D.",{"name":57,"role":47,"phone":18,"phoneExt":18,"email":18},"Jingqin (Rosy) Luo, Ph.D.",{"name":59,"role":47,"phone":18,"phoneExt":18,"email":18},"Christopher Abraham, M.D.",{"name":61,"role":47,"phone":18,"phoneExt":18,"email":18},"Michael Johnson, M.D.",{"type":63,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100601356","impact-of-an-electronic-health-record-maintenance-alert-on-psa-screening-rates-in-a-10-hospital-integrated-health-system-100601356",false,"NCT07109427","Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System","Eligibility Criteria:\n\n* Receive care within the BJC Health System\n* Have had at least one primary care physician appointment in the calendar year of PSA screening (primary care)\n* Be male\n* Not have a history of prostate cancer\n* Meet one of the following risk criteria:\n\n  * High Risk for Prostate Cancer\n\n    * African American, between the ages of 40 and 75 (inclusive), or\n    * Family history of prostate, breast, ovarian, and\u002For pancreatic cancer, or\n    * Known familial germline mutation OR\n  * Average Risk for Prostate Cancer\n\n    * Between the ages of 50 and 75 (inclusive)",true,"MALE","40 Years","75 Years",{"count":75,"type":76},40000,"ESTIMATED","INTERVENTIONAL",[79],"NA","\\- The investigators propose a clinical trial to evaluate the impact of annual shared decision making for PSA screening, supported by system-level enhancements to promote evidence-based care:\n\n* Defined referral thresholds within the health maintenance reminder, aligned with clinical risk stratification per NCCN guidelines.\n* Enhanced clinical decision support (CDS) tools to reduce provider variation and ensure guideline-concordant screening and referral practices.\n* The goal is to reduce late-stage presentation without increasing overdiagnosis-ensuring that prostate cancer screening is both accessible and clinically effective.",[82,83],"Prostate Cancer","Cancer of the Prostate",[85,86,87,88],"PSA Screening","Clinically Significant Prostate Cancer","African American men","Electronic Health Record","2025-08-12",{"date":91,"type":92},"2025-08-17","ACTUAL",{"date":94,"type":92},"2025-08-11",{"date":96,"type":76},"2031-08-31",{"name":5,"class":6},1]